 Bone marrow and peripheral blood samples are collected at baseline and at the completion of 3 courses of therapy for analysis of target cells myeloid blasts i.e., HLA class I receptor analysis and natural killer NK cell receptor ligand analysis and analysis of activating NK cell receptor alterations and NK-mediated cell killing. 